Investing.com - Patterson reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Patterson announced earnings per share of $0.63 on revenue of $1.6B. Analysts polled by Investing.com anticipated EPS of $0.57 on revenue of $1.68B.
Patterson shares are down 3% from the beginning of the year and are trading at $28.44 , down-from-52-week-high.
Patterson follows other major Healthcare sector earnings this month
Patterson's report follows an earnings beat by Novo Nordisk ADR on November 2, who reported EPS of $0.8409 on revenue of $6.04B, compared to forecasts EPS of $0.837 on revenue of $6.04B.
AstraZeneca ADR had beat expectations on November 10 with third quarter EPS of $1.67 on revenue of $10.98B, compared to forecast for EPS of $0.77 on revenue of $10.78B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar